Quantinuum Stock Has Tremendous Potential, but It Isn’t Cheap
Quantinuum (QNT), the quantum company in which Honeywell (HON) has a 48% stake, has tremendous potential. That's because QNT's technology is quite advanced and has already been validated to a large extent, according to multiple investment banks that recently published bullish notes about QNT stock.
Further, quantum technology itself is likely to be very useful and may be revolutionary, while the U.S. government is backing quantum in general and Quantinuum in particular, and QNT stock has a great deal of positive momentum at this point.
More News from Barchart
On the negative side, after QNT stock rose sharply since its debut on June 4 following the company's IPO, the stock is far from cheap, Quantinuum's most promising technology is not due out until 2029, and, as I've pointed out in past columns, the stocks of firms that focus on emerging technologies sometimes plunge sharply.
Still, long-term, risk-tolerant investors looking for an emerging-tech play should consider buying a small amount of QNT stock.
Highly Advanced, Validated Technology
In a recent note to investors, Bank of America wrote that Quantinuum's "newest platform, Helios, delivers industry-leading commercial performance," while multiple firms, including heavyweights Amgen (AMGN) and BMW (BMWKY), are already utilizing the system. J.P. Morgan added that Quantinuum's "Commercial momentum is building," while it has a "diversified...pipeline" of about $5 billion.
Since a meaningful number of companies, including sector powerhouses, have utilized and/or ordered Quantinuum's offerings, while it has a considerable pipeline, its products and technology have been validated to a large extent. And it appears that Helios is one of the world's top quantum platforms.
In May, McKinsey, the highly respected consulting firm, wrote that quantum could perform many valuable functions for companies and "solve problems that overwhelm classical computers, such as advanced simulation and probabilistic modeling." Among the functions that quantum may carry out are "drug discovery, material simulation, supply chain optimization, and financial modeling," the consulting firm reported.
Comments 0
Leave a Reply
Your email address will not be published. Required fields are marked *
Business & Finance
Explore AllBill Ackman Drives a Tesla: Here's Why He Won't Buy the Stock
FedEx Is Abandoning Its Supply Chain Business. FDX Stock Investors Need the Logistics Giant to Protect Its Core Network.
1 day agoQuantinuum Stock Has Tremendous Potential, but It Isn’t Cheap
1 day agoAMD Beats NVDA in 1H26 Returns. Here’s What's Next for 2H26.
1 day agoAeroVironment Posted Solid Earnings and the Stock Reacted Sharply Higher. If You Can Tolerate Risk, Buy Here.
1 day agoWhats New
View All
Bellingham inspires 10-man England in 3-2 last-16 thriller to beat Mexico
OPEC+ countries say they will expand monthly oil production
Ronaldo’s last World Cup? We will see, says Portugal star before Spain clash
How conflict minerals fuel war in eastern DR Congo amid US sanctions
‘The Vampire Lestat’ Costume Designer Breaks Down Lestat’s Rockstar Wardrobe and the Season’s Hidden Easter Eggs
‘House of the Dragon’ Star Steve Toussaint Teases Consequences of Corlys’ ‘Very Dangerous’ Request of Rhaenyra
From 'a beautiful night' to 'world's greatest hangover', guests react to Taylor and Travis's wedding
Neymar quits international football after Brazil’s World Cup knockout loss